Risk of Colorectal Cancer After Detection and Removal of Adenomas at Colonoscopy: Population-Based Case-Control Study

2012 ◽  
Vol 30 (24) ◽  
pp. 2969-2976 ◽  
Author(s):  
Hermann Brenner ◽  
Jenny Chang-Claude ◽  
Alexander Rickert ◽  
Christoph M. Seiler ◽  
Michael Hoffmeister

Purpose Empirical evidence for recommendations of surveillance intervals after detection and removal of adenomas at colonoscopy is still sparse and mostly based on observations of adenoma recurrence. We aimed to assess risk of colorectal cancer (CRC) according to time since polypectomy and factors that might be relevant for risk stratification. Methods In a population-based case-control study conducted in Germany, detailed history and results of previous large-bowel endoscopies were obtained by interview and from medical records. Risk of CRC among participants with detection of at least one adenoma at a preceding colonoscopy compared with participants without previous large-bowel endoscopy was assessed according to time since polypectomy among 2,582 cases with CRC and 1,798 matched controls. Results Adjusted odds ratios (95% CIs) of CRC for participants with polypectomy less than 3, 3 to 5, and 6 to 10 years ago (using participants without previous endoscopy as reference group) were 0.2 (0.2 to 0.3), 0.4 (0.3 to 0.6), and 0.9 (0.5 to 1.5), respectively. Strong, significant risk reduction within 5 years was consistently seen for women and men, younger and older participants, patients with and without high-risk polyps (three or more polyps, at least one polyp ≥ 1 cm, at least one polyp with villous components), and those with and without polypectomy in the right colon. With adjusted odds ratios of 0.1 (0.1 to 0.2), 0.3 (0.2 to 0.5) and 0.4 (0.2 to 0.8) for patients with polypectomy less than 3, 3 to 5, and 6 to 10 years ago, risk reduction was particularly strong for left-sided CRC. Conclusion Extension of surveillance intervals to 5 years should be considered, even after detection and removal of high-risk polyps.

2021 ◽  
Author(s):  
Josephina G. Kuiper ◽  
Aline C. Fenneman ◽  
Anne H. van der Spek ◽  
Elena Rampanelli ◽  
Max Nieuwdorp ◽  
...  

Objective: Whether an association between oral levothyroxine use, leading to supraphysiological exposure of the colon to thyroid hormones, and risk of colorectal cancer exists in humans is unclear. We therefore aimed to assess whether the use of levothyroxine is associated with a reduced risk of colorectal cancer in a linked cohort of pharmacy and cancer data. Design: Population-based matched case-control study. Methods: A total of 28,121 patients diagnosed with colorectal cancer between 1998-2014 were matched to 106,086 controls. Multivariable logistic regression was used to estimate the association between levothyroxine use and occurrence of colorectal cancer, adjusted for potential confounders. Results were stratified by gender, age, tumour subtype and staging as well as treatment duration and dosing. Results: A total of 1066 colorectal cancer patients (4%) and 4024 (4%) controls had used levothyroxine at any point before index date (adjusted odds ratio 0.95 [0.88-1.01]). Long-term use of levothyroxine was seen in 323 (30%) colorectal cancer patients and 1111 (28%) controls (adjusted odds ratio 1.00 [0.88-1.13]). Stratification by tumour subsite showed a borderline significant risk reduction of rectal cancer, while this was not seen for proximal colon cancer or distal colon cancer. There was no relationship with treatment duration or with levothyroxine dose. Conclusions: In this study, no reduced risk of colorectal cancer was seen in levothyroxine users. When stratifying by tumour subsite, a borderline significant risk reduction of rectal cancer was found and may warrant further research.


2020 ◽  
Author(s):  
Michael Hoffmeister ◽  
Hendrik Bläker ◽  
Lina Jansen ◽  
Elizabeth Alwers ◽  
Efrat L. Amitay ◽  
...  

AbstractObjectiveIn previous studies, the protective effect of colonoscopy was generally stronger for distal than for proximal colorectal cancer (CRC). This study aimed to investigate whether the association of colonoscopy and CRC risk varies according to major molecular pathological features and pathways of CRC.DesignPopulation-based case-control study from Germany, including 2132 patients with a first diagnosis of CRC and information on major molecular tumor markers, and 2486 control participants without CRC. Detailed participant characteristics were collected by standardized questionnaires and information on previous colonoscopy was derived from medical records. Polytomous logistic regression was used to calculate adjusted odds ratios (ORs) and 95% confidence intervals (95% CI) for the association between previous colonoscopy and subtypes of CRC.ResultsOverall, we observed strong risk reduction of CRC after colonoscopy that was weaker for microsatellite instable (MSI) than for non-MSI CRC (p for heterogeneity <0.01), for CpG island methylator phenotype (CIMP) high CRC than for CIMP low/negative CRC (p het<0.01), for BRAF-mutated than for BRAF non-mutated CRC (p het=0.01), for KRAS non-mutated than for KRAS-mutated CRC (p het=0.04), and for CRC classified into the sessile serrated pathway than for CRC of the traditional pathway (p het<0.01). After colonoscopy with detection of adenomas, no risk reduction was found for sessile serrated pathway CRC.ConclusionOur study extends the molecular understanding of existing differences in risk reduction of proximal and distal CRC reported by previous studies, and may imply important information for improving strategies for timely detection of relevant precursors.Summary BoxWhat is already known about this subject?Colonoscopy is an effective tool not only for early detection but also for prevention of colorectal cancer.In previous studies, risk reduction after colonoscopy was generally stronger for cancer of the distal colon and rectum than for cancer of the proximal colon.What are the new findings?This observational study found variation of colorectal cancer risk reduction after colonoscopy according to major molecular subtypes characteristic of the proximal colon (MSI, CIMP-high, BRAF mutation), and for colorectal cancer potentially developing via the sessile serrated pathway.How might it impact on clinical practice in the foreseeable future?This study contributes to the identification of molecular characteristics and associated phenotypes of potentially missed or more aggressive precursors.The study provides important information for improving strategies for a timely detection of relevant precursors at colonoscopy.


Endoscopy ◽  
2006 ◽  
Vol 37 (12) ◽  
Author(s):  
L Sharp ◽  
LF Masson ◽  
J Little ◽  
NT Brockton ◽  
SC Cotton ◽  
...  

2014 ◽  
Vol 71 (Suppl 1) ◽  
pp. A5.3-A6 ◽  
Author(s):  
Kyriaki Papantoniou ◽  
Manolis Kogevinas ◽  
Vicente Martin Sanchez ◽  
Victor Moreno ◽  
Marina Pollan ◽  
...  

2019 ◽  
Vol 50 (3) ◽  
pp. 295-305 ◽  
Author(s):  
Antonio Rodríguez-Miguel ◽  
Luis A. García-Rodríguez ◽  
Miguel Gil ◽  
Diana Barreira-Hernández ◽  
Sara Rodríguez-Martín ◽  
...  

In Vivo ◽  
2019 ◽  
Vol 33 (2) ◽  
pp. 573-579 ◽  
Author(s):  
CHIA-LING LIN ◽  
TA-CHUN LIU ◽  
YA-NI WANG ◽  
CHI-HSIANG CHUNG ◽  
WU-CHIEN CHIEN

2018 ◽  
Vol 75 (5) ◽  
pp. 344-350 ◽  
Author(s):  
Wa Mwenga Walasa ◽  
Renee N Carey ◽  
Si Si ◽  
Lin Fritschi ◽  
Jane S Heyworth ◽  
...  

ObjectiveResearch indicates that shiftwork may be associated with increased risks of adverse health outcomes, including some cancers. However, the evidence of an association between shiftwork and colorectal cancer risk is limited and inconclusive. Further, while several possible pathways through which shiftwork might result in cancer have been proposed, few studies have taken these factors into account. We investigated the association between two types of shiftwork (graveyard shiftwork and early-morning shiftwork) and six mechanistic shiftwork variables (including light at night and phase shift) and the risk of colorectal cancer among females in an Australian population-based case–control study. Graveyard shiftwork was the primary exposure of interest.MethodsParticipants (350 cases and 410 controls) completed a lifetime occupational history, and exposure to each of the eight shiftwork variables was assigned to participants through a job exposure matrix. We used logistic regression to calculate odds ratios (OR) and corresponding 95% confidence intervals (CI) for the association between different shiftwork variables and the risk of colorectal cancer, adjusting for potential demographic, lifestyle and medical confounders.ResultsWorking in an occupation involving long-term exposure (>7.5 years) to graveyard shiftwork was not associated with colorectal cancer risk (adjusted OR 0.95, 95% CI 0.57 to 1.58). Similarly, no increased risks of colorectal cancer were seen for any of the other seven shiftwork variables examined.ConclusionsNo evidence of an increased risk of colorectal cancer among females who had worked in occupations involving shiftwork was observed in this study.


PLoS ONE ◽  
2020 ◽  
Vol 15 (5) ◽  
pp. e0232740 ◽  
Author(s):  
Tzu-Chiao Lin ◽  
Wu-Chien Chien ◽  
Je-Ming Hu ◽  
Nian-Sheng Tzeng ◽  
Chi-Hsiang Chung ◽  
...  

2007 ◽  
Vol 133 (3) ◽  
pp. 755-760 ◽  
Author(s):  
Douglas J. Robertson ◽  
Heidi Larsson ◽  
Søren Friis ◽  
Lars Pedersen ◽  
John A. Baron ◽  
...  

2011 ◽  
Vol 7 (5) ◽  
pp. 431-438 ◽  
Author(s):  
Rune Erichsen ◽  
Christian Fynbo Christiansen ◽  
Frank Mehnert ◽  
Noel Scott Weiss ◽  
John Anthony Baron ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document